GADD45ß Loss Ablates Innate Immunosuppression in Cancer. (2018)
Attributed to:
Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-17-1833
PubMed Identifier: 29279355
Publication URI: http://europepmc.org/abstract/MED/29279355
Type: Journal Article/Review
Volume: 78
Parent Publication: Cancer research
Issue: 5
ISSN: 0008-5472